The FDA Super Bowl

<p>Every 5 years, the FDA has to renegotiate billions of dollars in user fees with the drug and medical device companies it regulates. This is one of those years, and Congress has to pass the latest user fee agreements by the end of September to keep FDA running. We break down this controversial process and what other health policies could pass in its wake.</p><br><p>Guest:</p><p><a href="https://pink.pharmaintelligence.informa.com/authors/sarah-karlin" rel="noopener noreferrer" target="_blank">Sarah Karlin-Smith</a>, Senior Writer, Pink Sheet</p><br><p>Read a full transcript and dig deeper into the issues explored in today's episode <a href="https://tradeoffs.org/2022/02/17/fda-user-fee-super-bowl/ " rel="noopener noreferrer" target="_blank">on our website</a>.</p><br><p>Support this type of journalism today by <a href="https://tradeoffs.org/donate" rel="noopener noreferrer" target="_blank">making a donation</a>.</p><br><p><a href="https://open.acast.com/shows/61435631f581aac8b8520e65/episodes/bit.ly/tradeoffsnewsletter" rel="noopener noreferrer" target="_blank">Sign up for our weekly newsletter</a> to see what research health policy experts are reading right now, plus recommendations from our staff.</p><br><p>Follow us on <a href="https://twitter.com/tradeoffspod" rel="noopener noreferrer" target="_blank">Twitter</a>.</p><br /><hr><p style='color:grey; font-size:0.75em;'> See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for privacy and opt-out information.</p>